Swiss medical regulators have approved a new malaria treatment for infants, offering hope to many in Africa KAMPALA, Uganda - ...

Antimalarial drug resistance is a pressing issue in combating the spread of malaria worldwide. In a new study, researchers from Children's Hospital of Philadelphia (CHOP) discovered a key process ...

Credit: Albert Guskov, University of Groningen The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.

The researchers analyzed the genomes of 724 malaria parasites evolved in the lab to resist one of 118 different antimalarial compounds, including both established treatments and new experimental ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers. In these diseases, a mutation in the genetic code ...

KYOTO, Japan — The antimalarial drug mefloquine may prove to be an effective treatment for progressive multifocal leukoencephalopathy (PML) in patients not infected with HIV, a small ...